GSK »

Bicycle Therapeutics shares owned by GSK

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by GSK from 13F filings

Historical chart of GSK investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by GSK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by GSK

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.5M 1.5M 4.24

More positions owned by GSK

Crispr Therapeutics Namen Akt (CRSP)
Wave Life Sciences SHS (WVE)
Vir Biotechnology (VIR)
Biontech Se Sponsored Ads (BNTX)
Ideaya Biosciences (IDYA)
Cytokinetics Com New (CYTK)
Lyell Immunopharma Com New (LYEL)
Spero Therapeutics (SPRO)
Nkarta (NKTX)
Fulcrum Therapeutics (FULC)
Bicycle Therapeutics Sponsored Ads (BCYC)
CVRX (CVRX)
Regenxbio Inc equity us cm (RGNX)

View all positions for GSK

Top funds holding Bicycle Therapeutics

Baker Bros. Advisors
Fcpm Iii Services B.v.
Armistice Capital
Long Focus Capital Management
Acadian Asset Management
Siren
Renaissance Technologies
GSK
T. Rowe Price Associates
Marshall Wace
Morgan Stanley
Schroder Investment Management Group
Diadema Partners
Birchview Capital
Silvercrest Asset Management Group

View all funds holding Bicycle Therapeutics